Jane Huang - Jun 7, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role: CMO, Hematology
Signature: /s/ Qing Nian, as Attorney-in-Fact
Stock symbol: BGNE
Transactions as of: Jun 7, 2021
Transactions value $: -$211,986
Form type: 4
Date filed: 6/9/2021, 04:45 PM
Previous filing: Jun 2, 2021
Next filing: Jun 10, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	American Depositary Shares	Sale	-$212K	-603	-100%	$351.55	0	Jun 7, 2021	Direct	F1, F2
holding	BGNE	Ordinary Shares						285K	Jun 7, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Content

Each American Depositary Share represents 13 Ordinary Shares.

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.